These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21748861)

  • 1. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
    van Hulst LT; Kievit W; van Bommel R; van Riel PL; Fraenkel L
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1407-14. PubMed ID: 21748861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis.
    Meyfroidt S; Hulscher M; De Cock D; Van der Elst K; Joly J; Westhovens R; Verschueren P
    Clin Rheumatol; 2015 May; 34(5):861-9. PubMed ID: 25711874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis.
    Kievit W; van Hulst L; van Riel P; Fraenkel L
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):842-7. PubMed ID: 20535795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
    Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
    De Cock D; Buckinx E; Pazmino S; Bertrand D; Stouten V; Westhovens R; Verschueren P
    Rheumatol Int; 2022 May; 42(5):815-823. PubMed ID: 34687348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
    Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
    Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria.
    Geens E; Geusens P; Vanhoof J; Berghs H; Praet J; Esselens G; Lens S; Dufour JP; Vandenberghe M; Van Mullem X; Westhovens R; Verschueren P
    Rheumatology (Oxford); 2009 May; 48(5):546-50. PubMed ID: 19254920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.
    Markusse IM; Dirven L; Han KH; Ronday HK; de Sonnaville PB; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):446-53. PubMed ID: 26239288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease activity-based management of rheumatoid arthritis in Dutch daily clinical practice has improved over the past decade.
    Spijk-de Jonge MJ; Weijers JM; Boerboom LWM; Huis AMP; Atsma F; Van Hulst LTC; van de Laar MAFJ; Hulscher MEJL; van Riel PLCM
    Clin Rheumatol; 2020 Apr; 39(4):1131-1139. PubMed ID: 31997083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.
    Díaz-Torné C; Urruticoechea-Arana A; Ivorra-Cortés J; Díaz S; Dilla T; Sacristán JA; Inciarte-Mundo J; Comellas M; Prades M; Lizán L
    Adv Ther; 2020 Apr; 37(4):1479-1495. PubMed ID: 32088860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.
    Kalkan A; Roback K; Hallert E; Carlsson P
    Implement Sci; 2014 Oct; 9():153. PubMed ID: 25304517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
    Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
    J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists.
    Péntek M; Gulácsi L; Rojkovich B; Brodszky V; van Exel J; Brouwer WB
    Eur J Health Econ; 2014 May; 15 Suppl 1():S83-92. PubMed ID: 24832839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient-centered knowledge translation tool for treat-to-target strategy in rheumatoid arthritis: Patient and rheumatologist perspectives.
    Benham H; Chiu H; Tesiram J; Mehdi A; Landsberg P; Grosman S; Harrison A; Nash P; Thomas R; Langbecker D; Van Driel M
    Int J Rheum Dis; 2021 Mar; 24(3):355-363. PubMed ID: 33470051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
    Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
    Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of rheumatoid arthritis in Turkey: a questionnaire study.
    Direskeneli H; Akkoç N; Bes C; Cakir N; Cefle A; Cobankara V; Dalkilic E; Dinc A; Ertenli I; Gul A; Hamuryudan V; Inanc M; Kalyoncu U; Karaaslan Y; Kasifoglu T; Keser G; Keskin G; Kisacik B; Kiraz S; Masatlioglu S; Onat AM; Ozbek S; Ozturk MA; Pamuk ON; Pay S; Pirildar T; Sayarlioglu M; Senel S; Senturk T; Tasan D; Terzioglu E; Yazici A; Yucel E
    Clin Exp Rheumatol; 2014; 32(4):477-83. PubMed ID: 24960289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
    Lesuis N; van Vollenhoven RF; Akkermans RP; Verhoef LM; Hulscher ME; den Broeder AA
    Clin Exp Rheumatol; 2018; 36(1):21-28. PubMed ID: 28598775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are rheumatologists' treatment decisions influenced by patients' age?
    Fraenkel L; Rabidou N; Dhar R
    Rheumatology (Oxford); 2006 Dec; 45(12):1555-7. PubMed ID: 16690762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative.
    Omair MA; Omair MA; Halabi H
    Int J Rheum Dis; 2017 Sep; 20(9):1185-1192. PubMed ID: 26354409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.